ÂÜÀòÂÒÂ×

Dr. Tim Kutzkey serves as Chairman on Neurona’s Board of Directors. He is currently a Managing Partner at The Column Group (TCG). Since joining TCG in 2007, Dr. Kutzkey has contributed to the conception, formation, and management of many of the firm’s portfolio companies. In addition to Neurona, he is currently a Board Director of Peloton Therapeutics, a company he launched in 2010 as the President and CEO. Dr. Kutzkey also serves on the Board of Directors of Surrozen, Nura Bio, Carmot Therapuetics, Kallyope, Plexium, Synthekine and Cajal Neuroscience. Dr. Kutzkey was formerly a scientist at KAI Pharmaceuticals, focused on the discovery and development of selective protein kinase C inhibitors. Prior to KAI, he worked at UC Berkeley as a graduate student and postdoctoral scholar in the lab of Dr. Robert Tjian, completing his Ph.D. in molecular and cell biology in 2005. Dr. Kutzkey was previously educated at Stanford University.